Product Description

Ponaxen Tablets 15mg contains Ponatinib, a tyrosine kinase inhibitor used to treat certain types of Philadelphia chromosome-positive leukemia, including CML and ALL in appropriate patients.

Product Overview

Product Name: Ponaxen Tablets 15mg

Generic Name: Ponatinib

Strength: 15mg

Form: Tablets

Pack Size: As per manufacturer packaging

Used For: Selected Philadelphia chromosome-positive leukemias

Prescription Required: Yes

Ingredients & How They Work

Each tablet contains Ponatinib 15mg, which inhibits abnormal tyrosine kinase proteins including BCR-ABL. It is also active against certain resistant BCR-ABL mutations.

Key Benefits

• Used in selected CML cases
• Used in certain Philadelphia chromosome-positive ALL
• Targets abnormal BCR-ABL signaling
• Active against certain resistant mutations
• Oral targeted cancer therapy

How to Use

Take exactly as prescribed by your oncologist. Swallow the tablet whole with water and follow the prescribed dosing schedule.

Side Effects & Precautions

Possible Side Effects

• High blood pressure
• Fatigue
• Rash
• Abdominal discomfort
• Changes in blood counts

Precautions

• Ponatinib can cause serious cardiovascular and blood-vessel complications.
• Blood pressure and cardiovascular health require monitoring.
• Report chest pain, shortness of breath, severe headache, or sudden weakness immediately.
• Do not change the dose without specialist advice.

Storage Instructions

Store below 30°C in a cool, dry place away from moisture and direct sunlight.